Guest guest Posted April 8, 2011 Report Share Posted April 8, 2011 DIAD: Division of Immunotherapy and Autoimmune Diseases anyone that has MS, Devic's and is not doing well with LDN or prescription drugs should check this web site out Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 8, 2011 Report Share Posted April 8, 2011 What is even greater about stem cell is that the adipose method now makes adult stem cell even better because it produces 10 times the number of stem cells than bone marrow and is less invasive. Judy and I just returned from having adult stem cell in the Dominican Republic. Looking forward to seeing the results we get over the next 3 months. You can join the stem cell group to learn more by going to StemCellDR@ Also it is now about 1/3 to 1/2 the original cost if you go to the Dominican Republic. Stem cell is now only $6500 which includes the beautiful resort hotel. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 17, 2011 Report Share Posted April 17, 2011 By Chris' own admission, transplants result in an overall survival of 65%. Since transplants aren't usually done on healthy patients at diagnosis, but reserved for the time when all else fails, 65% survival isn't that bad. The alternative is probably 10% survival without the transplant. You do the math. Sometimes people are just negative without justification. (It's not something to take lightly, but faced with certainty of death, it may be an option for some. I've seen a number of people recently who have had transplants, and some of them do pretty well. Remember, Dr. Hamblin only has the English experience, and not what Stanford or Hutchinson in Seattle can do.) ___________________________________ Posted by: " cllcanada " Apr 10, 2011 10:02 am <snipped by moderator> The recent major allogeneic stem cell transplantation clinical trial, CLL3X from German, with a median follow up of 46 months found, achieved 4-year nonrelapse mortality (NRM) of 23%, event-free survival (EFS) 42%, and overall survival (OS) 65%. This is hardly a cure... ~chris Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 17, 2011 Report Share Posted April 17, 2011 That is a 4 year overall survival of 65% based on one study. These were NOT patients on death's doorstep... They were 'Poor-Risk' patients...based on the follow criteria: quote Eligible were patients with poor-risk CLL as defined by one of the following: refractoriness or early relapse (within 12 months) after treatment with a purine analogue-containing regimen, relapse after autologous SCT, or progressive disease in the presence of an unfavourable genetic constellation (11q-, 17p-, and/or unmutated IGHV status and/or usage of the VH3-21 gene). Patients had to be between 18 and 65 years of age with normal organ function and an Eastern ative Oncology Group (ECOG) performance status of 1 or better. end quote Want the facts, read the paper: http://bloodjournal.hematologylibrary.org/content/116/14/2438.full.pdf or http://tinyurl.com/3wnf8yg ~chris Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.